Keyword: Checkmate Pharmaceuticals
Gilead names Dickinson to CFO role; MedImmune CSO Herbst nabs CSO job at Pyxis; Checkmate picks up Wooldridge for CMO.
Next-gen cancer biotech Checkmate Pharmaceuticals has grabbed a new chief medical officer after a year of C-suite shuffles.
Merck and OncoSec partnered on a second immunotherapy combination, now in triple-negative breast cancer, following a melanoma study last year.
A combination of Checkmate's TLR9 agonist and Merck's Keytruda reversed PD-1 resistance in melanoma patients.
A new funding round for Checkmate Pharma will fund additional trials of immuno-oncology drug CMP-001.